Preventive health clinics / centers
Repeatable commercial adoption is now visible across several independent preventive care providers. Demand is no longer limited to isolated early validation, although scale and retention remain uneven.
ConfidenceMedium
Assessed as of
Current state, informed by 36 months and relevant older history.
Assessment methodologySupporting sources (6)
- Year three data story shows scan and referral outcomes
- Kor reports adoption across more than 8,000 companies and health insurers
- Statutory insurer mkk begins covering Skleo eye screening
- Axo Longevity reports six-market rollout and 19,000+ waitlist
- Ahead Health raises $10 million and expands into Germany and the Netherlands
- Neko Health opens its first U.S. office in New York
A small group of providers has moved clearly ahead in operating scale and market presence, while a larger set remains much earlier. The category now shows a visible gap between leaders and the long tail.
ConfidenceMedium
Supporting sources (6)
- Neko Health opens its first U.S. office in New York
- Year three data story shows scan and referral outcomes
- $450M growth financing from General Catalyst
- Kor reports adoption across more than 8,000 companies and health insurers
- Statutory insurer mkk begins covering Skleo eye screening
- Ahead Health raises $10 million and expands into Germany and the Netherlands
Substantive developments continue across several independent providers. Market expansion, distribution gains and product broadening are occurring without a broad enough shift to qualify as intense.
ConfidenceMedium
Supporting sources (6)
- Neko Health opens its first U.S. office in New York
- Superpower partners with Sequoia for employer distribution
- Statutory insurer mkk begins covering Skleo eye screening
- Aeon acquires Aware Health
- Ahead Health raises $10 million and expands into Germany and the Netherlands
- Axo Longevity reports six-market rollout and 19,000+ waitlist
Venture funding has strengthened exceptionally, with very large financings now spread across more than one leading provider. Capital remains concentrated, but the increase is material in both scale and strategic importance.
ConfidenceMedium
Supporting sources (5)
Preventive care products continue to broaden beyond one off screening into ongoing monitoring and more integrated follow up. The dominant direction remains expansion rather than simple refinement.
ConfidenceMedium
Supporting sources (6)
- Body composition and wearables integration added to the Neko Health Scan
- Aeon adds longitudinal blood diagnostics to preventive-health platform
- AI Doctor added support for larger files
- Function acquires SuppCo to add supplement guidance
- Ahead membership launched
- Launched 30-second cardiovascular risk scan
Independent participation remains broadly stable. Recent exits and acquisitions now provide clearer consolidation signals, but they do not yet outweigh continued participation and expansion by other providers.
ConfidenceMedium
| Company | Score | Movement | History |
|---|---|---|---|
| 85 | +3 | ||
| 83 | +4 | ||
| 61 | +6 | ||
| 58 | +9 | ||
| 58 | +6 | ||
| 57 | — | ||
| 50 | +6 | ||
| 49 | +3 | ||
| 44 | +6 | ||
| 42 | +8 | ||
| 39 | +5 | ||
| 36 | +10 | ||
| 5 | -43 |